Despite its physiological functions, it has been demonstrated that FGF-23 is involved in systemic atherosclerosis via nitric-oxide-associated endothelial dysfunction and calcium-phosphate-related bone mineralization [16]. This evidence concerns the gene FGF23 and endothelial dysfunction.